Bon Natural Life Limited (BON) P/E Ratio History
Deep ValueTrading at -1.6x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2021–2025
Loading P/E history...
P/E Ratio Analysis
As of June 29, 2026, Bon Natural Life Limited (BON) trades at a price-to-earnings ratio of -1.6x, with a stock price of $1.13 and trailing twelve-month earnings per share of $-0.58.
The current P/E is 104% below its 5-year average of 41.3x. Over the past five years, BON's P/E has ranged from a low of 0.7x to a high of 165.6x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Consumer Defensive sector median P/E of 19.4x, BON trades at a 108% discount to its sector peers. The sector includes 151 companies with P/E ratios ranging from 0.0x to 193.7x.
Relative to the broader market, BON trades at a notable discount to the S&P 500 median P/E of 25.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our BON DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
BON Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
BON P/E vs Peers
Food ingredients and pet food peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $70M | 13.1Lowest | 2.18 | -61% | |
| $370M | 19.8 | - | +165%Best | |
| $22B | 33.4 | - | +46% | |
| $40B | 22.2 | 0.41Best | -4% | |
| $17B | 50.7 | - | -22% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
BON Historical P/E Data (2021–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | Mar 31 2025 | $2.34 | $3.31 | 0.7x | -98% |
| FY2024 Q4 | Sep 30 2024 | $48.75 | $5.17 | 9.4x | -77% |
| FY2024 Q2 | Mar 31 2024 | $102.75 | $9.34 | 11.0x | -73% |
| FY2023 Q4 | Sep 30 2023 | $100.75 | $12.39 | 8.1x | -80% |
| FY2023 Q2 | Mar 31 2023 | $355.00 | $12.78 | 27.8x | -33% |
| FY2022 Q4 | Sep 30 2022 | $540.75 | $14.41 | 37.5x | -9% |
| FY2022 Q2 | - | $902.50 | $12.86 | 70.2x | +70% |
| FY2021 Q4 | - | $2117.50 | $12.79 | 165.6x | +301% |
Average P/E for displayed period: 41.3x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BON — Frequently Asked Questions
Quick answers to the most common questions about buying BON stock.
What is BON's P/E ratio?
Bon Natural Life Limited (BON) trailing twelve-month P/E ratio is -1.6x, based on TTM diluted EPS of $-0.58. The 5-year average P/E is 41.3x and the historical range spans 0.7x to 165.6x.
Is BON stock overvalued or undervalued?
BON trades at -1.6x P/E, below its 5-year average of 41.3x. At the 0th percentile of its historical range (0.7x–165.6x), the stock is priced at a discount to its own history.
Is BON stock expensive?
No, BON is not expensive on a historical basis. The current P/E of -1.6x is below the 5-year average of 41.3x and sits at the 0th percentile of its valuation range.
What is BON's historical P/E range?
Over the past 5 years, BON's P/E ratio has ranged from 0.7x to 165.6x, with a median of 27.8x and an average of 41.3x. The current P/E of -1.6x places the stock at the 0th percentile of this range. Full historical data spans 2021–2025.
How does BON's P/E compare to the S&P 500?
BON trades at -1.6x P/E versus the S&P 500 median of 25.3x. The 106% discount to the market suggests lower growth expectations or perceived higher risk.
How does BON's valuation compare to Consumer Defensive peers?
Bon Natural Life Limited P/E of -1.6x compares to the Consumer Defensive sector median of 19.4x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is BON's PEG ratio?
BON PEG ratio is N/A, based on a P/E of -1.6x and EPS growth of -523.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is BON's earnings yield?
BON earnings yield is N/A, the inverse of its -1.6x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.